CybeRelease: (OTC: IDWD) Division Gets $50 Million Agreement

(CybeRelease, March 21, 2006) - Lake Harmony, PA - IDS Worldwide, Inc. (OTC PK: IDWD) recently announced that IDS Homeland Security Divisions (HLS) leading biometric encryption technology, the most advanced IT Security Product available in the world combining Biometric Technology and IDS HLS Division proprietary 384-Bit Encryption Algorithm, has signed a $50 million Distributor Agreement for North America for the Healthcare Industry to meet HIPAA requirements with Strategic Acquisitions LLC. The first 50,000 units are scheduled for delivery before May 15, 2006, and subsequent deliveries for an additional 450,000 units throughout the coming year. Strategic Acquisitions LLC was also granted first right of refusal for additional biometric technology for the healthcare industry that has not yet been released by HLS. HIPAA legislation now requires healthcare facilities such as doctor offices and hospitals to undertake security measures to assure both the security and portability of a patient’s healthcare records. This security and portability cannot be accomplished with outdated security measures such as computer passwords and outdated file protection systems. The average doctor’s office contains approximately 10-20 computers, and most hospitals’ computer terminals number in the hundreds.

For more information, go to www.cyberelease.com/idwd32106.htm.

CybeRelease Gainers are Healthways, Inc. (Nasdaq: HWAY), Quigley Corporation (The) (Nasdaq: QGLY), Hydrogenics Corporation (Nasdaq: HYGS), NitroMed, Inc. (Nasdaq: NTMD), Leading Brands Inc. (Nasdaq: LBIX), Acacia Research Corporation (Nasdaq: CBMX), SatCon Technology Corporation (Nasdaq: SATC) and Capstone Turbine Corporation (Nasdaq: CPST).

CybeRelease Decliners are China TechFaith Wireless Communication Technology Limited (Nasdaq: CNTF), Progress Software Corporation (Nasdaq: PRGS), Nymox Pharmaceutical Corporation (Nasdaq: NYMX), Novavax, Inc. (Nasdaq: NVAX), Viewpoint Corporation (Nasdaq: VWPT), Interface, Inc. (Nasdaq: IFSIA), EMCORE Corporation (Nasdaq: EMKR) and Biomet, Inc. (Nasdaq: BMET).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $445.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.

Contact Information

C. P. Barry

Media Contact

CybeRelease.com

Contact via E-mail